Skip to main content
. 2021 Apr 19;11:8464. doi: 10.1038/s41598-021-87340-6

Table 4.

C3a and treatment outcomes at twelve months.

Analyte C3a at baseline C3a at 2 months
P value P value
logMAR change rs = − 0.0744 0.662 rs = − 0.2006 0.234
Number of injections rs = 0.0806 0.635 rs = 0.0864 0.611
Dry macula (22 of 37 eyes) median (IQR) 2654 pg/mL (2167–3338) 0.687 2727 pg/mL (2332–3144) 0.621

rs: correlation of Spearman’s analysis.

C3a, complement component 3a; VEGF, vascular endothelial growth factor.